Envestnet Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $74.9K | Sell |
15,868
-496
| -3% | -$2.34K | ﹤0.01% | 4369 |
|
|
2025
Q1 | $75.1K | Buy |
+16,364
| New | +$75.1K | ﹤0.01% | 4266 |
|
|
2024
Q4 | – | Sell |
-25,496
| Closed | -$120K | – | 4408 |
|
|
2024
Q3 | $120K | Buy |
25,496
+1,409
| +6% | +$6.61K | ﹤0.01% | 4105 |
|
|
2024
Q2 | $136K | Buy |
+24,087
| New | +$136K | ﹤0.01% | 4015 |
|
|
2023
Q4 | – | Sell |
-25,933
| Closed | -$112K | – | 4176 |
|
|
2023
Q3 | $112K | Buy |
25,933
+4,977
| +24% | +$21.5K | ﹤0.01% | 3854 |
|
|
2023
Q2 | $138K | Buy |
20,956
+1,180
| +6% | +$7.78K | ﹤0.01% | 3788 |
|
|
2023
Q1 | $134K | Buy |
19,776
+1,932
| +11% | +$13.1K | ﹤0.01% | 3746 |
|
|
2022
Q4 | $132K | Buy |
17,844
+6,634
| +59% | +$49K | ﹤0.01% | 3760 |
|
|
2022
Q3 | $111K | Buy |
11,210
+1,146
| +11% | +$11.3K | ﹤0.01% | 3717 |
|
|
2022
Q2 | $110K | Buy |
+10,064
| New | +$110K | ﹤0.01% | 3747 |
|
|
2022
Q1 | – | Sell |
-10,698
| Closed | -$168K | – | 4071 |
|
|
2021
Q4 | $168K | Buy |
+10,698
| New | +$168K | ﹤0.01% | 3686 |
|
|
2020
Q1 | – | Sell |
-11,685
| Closed | -$192K | – | 3145 |
|
|
2019
Q4 | $192K | Buy |
11,685
+889
| +8% | +$14.6K | ﹤0.01% | 2931 |
|
|
2019
Q3 | $143K | Buy |
10,796
+444
| +4% | +$5.88K | ﹤0.01% | 2924 |
|
|
2019
Q2 | $146K | Buy |
10,352
+162
| +2% | +$2.29K | ﹤0.01% | 2924 |
|
|
2019
Q1 | $187K | Buy |
+10,190
| New | +$187K | ﹤0.01% | 2843 |
|